Targeted protein degradation is being explored instead method in cancer, whereby the purely natural protein degradation process is co-opted for therapeutic applications. Not long ago made novel molecules called proteolysis-focusing on chimeras (PROTACs) are heterobifunctional molecules with two ligands joined by a linker. 1 ligand binds towards th